CUA Educational Content

ELEVATE: Optimizing the Use of ARPIs in Castration-Sensitive Prostate Cancer

Speakers: Christian Kollmannsberger, Tony Finelli, Andrew Feifer

Objectives:

  • Understand the efficacy and safety data from randomized controlled trials investigating ADT + ARPI
  • Consider the appropriate treatment course and utilize practical strategies for managing patients diagnosed with mCSPC
  • Apply the Canadian Urological Association guidelines on mCSPC and other decision support tools to clinical practice
Start Quiz for Credits

This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.

This program has received financial support from Astellas in the form of an educational grant.

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy